Home /Research /Fluoroquinolone Exposure and Cancer Risk in Interstitial Lung Disease: A Propensity-Score-Matched Cohort Study Using Cox and Competing-Risk Models.
OTHER

Fluoroquinolone Exposure and Cancer Risk in Interstitial Lung Disease: A Propensity-Score-Matched Cohort Study Using Cox and Competing-Risk Models.

Sun YF, Chiu YT, Ko YE, Huang YW, Hsieh LK, Lin CL, Kao CH, Yeh JJ

Year
2026
Journal
Pharmaceuticals (Basel, Switzerland)

Keywords

fluoroquinolonecancer riskinterstitial lung diseasecohort study

Related papers

Browse all OTHER papers